Detalles de la búsqueda
1.
Advances and Challenges in Interventional Immuno-Oncology Locoregional Therapies.
J Vasc Interv Radiol
; 35(2): 164-172, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38272636
2.
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 22(7): 931-945, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34051178
3.
Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab.
Int J Clin Oncol
; 26(8): 1506-1513, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34023933
4.
Adding taxane to platin-5-fluorouracil combination does not improve survival rate in patients ≥ 65 years of age with advanced gastric cancer: A retrospective-multicenter study.
J BUON
; 23(2): 416-421, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29745086
5.
Preoperative neutrophil-to-lymphocyte ratio and plateletto- lymphocyte ratio as new prognostic factors for patients with colorectal cancer.
J BUON
; 21(5): 1153-1157, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27837617
6.
Expression patterns of claudins 1, 4, and 7 and their prognostic significance in nasopharyngeal carcinoma.
J BUON
; 20(1): 212-7, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25778318
7.
Is there any relation between PET-CT SUVmax value and prognostic factors in locally advanced breast cancer?
J BUON
; 20(5): 1282-6, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26537076
8.
Prognostic factors in clinical stage T4N2 locally advanced non-small cell lung cancer.
J BUON
; 20(2): 573-9, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26011352
9.
The Optimal Treatment Modality in Patients with T4N2M0 Non-Small Cell Lung Cancer: The Best Choice May Be Definitive Chemoradiotherapy Followed by Consolidation Chemotherapy.
Chemotherapy
; 60(2): 107-111, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25721008
10.
The effect of autoimmunity on the development time of microvascular complications in patients with type 1 diabetes mellitus.
Med Sci Monit
; 20: 1176-9, 2014 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-25007947
11.
Use of chemotherapy at the end of life in Turkey.
BMC Palliat Care
; 13(1): 51, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25435808
12.
Yttrium-90 radioembolization in patients with unresectable liver metastases: determining the factors that lead to treatment efficacy.
Hepatogastroenterology
; 61(134): 1529-34, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25436337
13.
Prolonged progression-free survival with maintenance metronomic oral cyclophosphamide and etoposide treatment in macroscopic residual disease or recurrent/advanced stage ovarian cancer.
J BUON
; 19(4): 980-4, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25536605
14.
Bioengineered Ionic Liquid for Catheter-Directed Tissue Ablation, Drug Delivery, and Embolization.
Adv Mater
; : e2309412, 2024 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38305472
15.
Catheter-Directed Ionic Liquid Embolic Agent for Rapid Portal Vein Embolization, Segmentectomy, and Bile Duct Ablation.
Adv Mater
; : e2402570, 2024 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38678378
16.
Silk Embolic Material for Catheter-Directed Endovascular Drug Delivery.
Adv Mater
; 34(2): e2106865, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34695275
17.
Effects of Primary Tumor Resection on Metastatic Breast Cancer Survival and the Predictive Power of Neutrophil: Lymphocyte Ratio on Prognosis.
Eur J Breast Health
; 17(4): 322-327, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34651110
18.
Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences.
Eur Urol Focus
; 7(5): 1061-1066, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33008789
19.
Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial
Balkan Med J
; 37(2): 104-107, 2020 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31970972
20.
Hyperprogression after immunotherapy: A comprehensive review.
J BUON
; 24(6): 2232-2241, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31983088